STADA: Purchase of a generics business in Switzerland successfully concluded
31/01/2012
STADA: Purchase of a generics business in Switzerland successfully concluded
Related Posts
STADA and Calliditas - filing for full marketing authorization for Kinpeygo® in the EU
STADA and Calliditas announce the filing for full marketing authorization for Kinpeygo® in the EU
CapVest to acquire majority stake in STADA from Bain Capital and Cinven
CapVest to acquire majority stake in STADA from Bain Capital and Cinven
FRANKFURT / LONDON – September 1, 2025 – International private equity firms, Bain Capital and Cinven, today announced that they have signed a definitive agreement to sell a majority stake in STADA Arzneimittel AG (“STADA”) to CapVest Partners LLP (“CapVest”).
FRANKFURT / LONDON – September 1, 2025 – International private equity firms, Bain Capital and Cinven, today announced that they have signed a definitive agreement to sell a majority stake in STADA Arzneimittel AG (“STADA”) to CapVest Partners LLP (“CapVest”).
